Luye Pharma Group Ltd has announced its acquirement of the entire issued share capital of Acino AG and Acino Supply AG for a purchase consideration of $268.8m.

The acquisition is expected to be completed in the second half of 2016.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The transaction will allow Luye Pharma to improve its international approach and gain access to boarder therapeutic areas and will help Acino AG to grow in its key market.

China Resources Sanjiu Medical & Pharmaceutical Co. Ltd has announced to acquire Kunming Shenghuo Pharmaceutical for a purchase consideration of $282.67m.

The company will fund the entire costs associated with the acquisitions through its own funds.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
YPrime won the Innovation award for AI in Clinical Trials and the Environmental award for Sustainable Trials, thanks to its eCOA, IRT and eConsent platforms. Explore how purpose-built AI, paperless workflows and circular hardware practices are reshaping timelines, data quality and ESG performance in clinical research.

Discover the Impact